Review



anti sox2  (R&D Systems)


Bioz Verified Symbol R&D Systems is a verified supplier
Bioz Manufacturer Symbol R&D Systems manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 97

    Structured Review

    R&D Systems anti sox2
    Anti Sox2, supplied by R&D Systems, used in various techniques. Bioz Stars score: 97/100, based on 727 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mouse+anti+sox2/Human%2FMouse%2FRat+SOX2+Antibody/pm42032298-92-12-15
    Average 97 stars, based on 727 article reviews
    anti sox2 - by Bioz Stars, 2026-09
    97/100 stars

    Images

    Related Articles

    Immunohistochemistry:

    Article Title: Dmd mdx mice have defective oligodendrogenesis, delayed myelin compaction and persistent hypomyelination
    Article Snippet: .. The following primary antibodies were used at indicated dilutions: mouse anti-APC/CC1 [immunohistochemistry (IHC) 1:20; Millipore OP80], mouse anti-CNP [western blotting (WB) 1:1000; Millipore C5922], rabbit anti-Dystrophin (WB 1 μg/ml, Abcam AB15277), mouse anti-beta-dystroglycan (WB 1:250; Developmental Studies Hybridoma Bank), rat anti-Ki67 (IHC: 1:100, Invitrogen 4-5698-82), rat anti-MBP (IHC 1:200; WB 1:1000; BioRad AA82-87), rabbit anti-Histone H3 (1:750; Santa Cruz), rabbit anti-MOG (WB: 1:1000; Abcam ab108505), rabbit anti-GFAP (1:1000; DAKO), rabbit anti-Olig2 (IHC 1:100; Millipore AB9610), goat anti-PDGFRα , (IHC 1:100; R&D Systems AF1062), mouse anti-SOX2 (IHC 1:100; R&D Systems MAB2018), mouse (IgG1) anti-β-Catenin [immunofluorescence (IF) Wholemount 1:500; BD Transduction Labs 610153], rabbit anti-γ-Tubulin (IF Wholemount 1:500; Sigma T5192). ..

    Article Title: Dmd mdx mice have defective oligodendrogenesis, delayed myelin compaction and persistent hypomyelination.
    Article Snippet: .. The following primary antibodies were used at indicated dilutions: mouse anti-APC/CC1 [immunohistochemistry (IHC) 1:20; Millipore OP80], mouse anti-CNP [western blotting (WB) 1:1000; Millipore C5922], rabbit anti-Dystrophin (WB 1 μg/ml, Abcam AB15277), mouse anti-betadystroglycan (WB 1:250; Developmental Studies Hybridoma Bank), rat anti-Ki67 (IHC: 1:100, Invitrogen 4-5698-82), rat anti-MBP (IHC 1:200; WB 1:1000; BioRad AA82-87), rabbit anti-Histone H3 (1:750; Santa Cruz), rabbit anti-MOG (WB: 1:1000; Abcam ab108505), rabbit anti-GFAP (1:1000; DAKO), rabbit anti-Olig2 (IHC 1:100; Millipore AB9610), goat anti-PDGFRα , (IHC 1:100; R&D Systems AF1062), mouse anti-SOX2 (IHC 1:100; R&D Systems MAB2018), mouse (IgG1) anti-β-Catenin [immunofluorescence (IF) Wholemount 1:500; BD Transduction Labs 610153], rabbit anti-γ-Tubulin (IF Wholemount 1:500; Sigma T5192). ..

    Western Blot:

    Article Title: Dmd mdx mice have defective oligodendrogenesis, delayed myelin compaction and persistent hypomyelination
    Article Snippet: .. The following primary antibodies were used at indicated dilutions: mouse anti-APC/CC1 [immunohistochemistry (IHC) 1:20; Millipore OP80], mouse anti-CNP [western blotting (WB) 1:1000; Millipore C5922], rabbit anti-Dystrophin (WB 1 μg/ml, Abcam AB15277), mouse anti-beta-dystroglycan (WB 1:250; Developmental Studies Hybridoma Bank), rat anti-Ki67 (IHC: 1:100, Invitrogen 4-5698-82), rat anti-MBP (IHC 1:200; WB 1:1000; BioRad AA82-87), rabbit anti-Histone H3 (1:750; Santa Cruz), rabbit anti-MOG (WB: 1:1000; Abcam ab108505), rabbit anti-GFAP (1:1000; DAKO), rabbit anti-Olig2 (IHC 1:100; Millipore AB9610), goat anti-PDGFRα , (IHC 1:100; R&D Systems AF1062), mouse anti-SOX2 (IHC 1:100; R&D Systems MAB2018), mouse (IgG1) anti-β-Catenin [immunofluorescence (IF) Wholemount 1:500; BD Transduction Labs 610153], rabbit anti-γ-Tubulin (IF Wholemount 1:500; Sigma T5192). ..

    Article Title: Dmd mdx mice have defective oligodendrogenesis, delayed myelin compaction and persistent hypomyelination.
    Article Snippet: .. The following primary antibodies were used at indicated dilutions: mouse anti-APC/CC1 [immunohistochemistry (IHC) 1:20; Millipore OP80], mouse anti-CNP [western blotting (WB) 1:1000; Millipore C5922], rabbit anti-Dystrophin (WB 1 μg/ml, Abcam AB15277), mouse anti-betadystroglycan (WB 1:250; Developmental Studies Hybridoma Bank), rat anti-Ki67 (IHC: 1:100, Invitrogen 4-5698-82), rat anti-MBP (IHC 1:200; WB 1:1000; BioRad AA82-87), rabbit anti-Histone H3 (1:750; Santa Cruz), rabbit anti-MOG (WB: 1:1000; Abcam ab108505), rabbit anti-GFAP (1:1000; DAKO), rabbit anti-Olig2 (IHC 1:100; Millipore AB9610), goat anti-PDGFRα , (IHC 1:100; R&D Systems AF1062), mouse anti-SOX2 (IHC 1:100; R&D Systems MAB2018), mouse (IgG1) anti-β-Catenin [immunofluorescence (IF) Wholemount 1:500; BD Transduction Labs 610153], rabbit anti-γ-Tubulin (IF Wholemount 1:500; Sigma T5192). ..

    Immunofluorescence:

    Article Title: Dmd mdx mice have defective oligodendrogenesis, delayed myelin compaction and persistent hypomyelination
    Article Snippet: .. The following primary antibodies were used at indicated dilutions: mouse anti-APC/CC1 [immunohistochemistry (IHC) 1:20; Millipore OP80], mouse anti-CNP [western blotting (WB) 1:1000; Millipore C5922], rabbit anti-Dystrophin (WB 1 μg/ml, Abcam AB15277), mouse anti-beta-dystroglycan (WB 1:250; Developmental Studies Hybridoma Bank), rat anti-Ki67 (IHC: 1:100, Invitrogen 4-5698-82), rat anti-MBP (IHC 1:200; WB 1:1000; BioRad AA82-87), rabbit anti-Histone H3 (1:750; Santa Cruz), rabbit anti-MOG (WB: 1:1000; Abcam ab108505), rabbit anti-GFAP (1:1000; DAKO), rabbit anti-Olig2 (IHC 1:100; Millipore AB9610), goat anti-PDGFRα , (IHC 1:100; R&D Systems AF1062), mouse anti-SOX2 (IHC 1:100; R&D Systems MAB2018), mouse (IgG1) anti-β-Catenin [immunofluorescence (IF) Wholemount 1:500; BD Transduction Labs 610153], rabbit anti-γ-Tubulin (IF Wholemount 1:500; Sigma T5192). ..

    Article Title: Dmd mdx mice have defective oligodendrogenesis, delayed myelin compaction and persistent hypomyelination.
    Article Snippet: .. The following primary antibodies were used at indicated dilutions: mouse anti-APC/CC1 [immunohistochemistry (IHC) 1:20; Millipore OP80], mouse anti-CNP [western blotting (WB) 1:1000; Millipore C5922], rabbit anti-Dystrophin (WB 1 μg/ml, Abcam AB15277), mouse anti-betadystroglycan (WB 1:250; Developmental Studies Hybridoma Bank), rat anti-Ki67 (IHC: 1:100, Invitrogen 4-5698-82), rat anti-MBP (IHC 1:200; WB 1:1000; BioRad AA82-87), rabbit anti-Histone H3 (1:750; Santa Cruz), rabbit anti-MOG (WB: 1:1000; Abcam ab108505), rabbit anti-GFAP (1:1000; DAKO), rabbit anti-Olig2 (IHC 1:100; Millipore AB9610), goat anti-PDGFRα , (IHC 1:100; R&D Systems AF1062), mouse anti-SOX2 (IHC 1:100; R&D Systems MAB2018), mouse (IgG1) anti-β-Catenin [immunofluorescence (IF) Wholemount 1:500; BD Transduction Labs 610153], rabbit anti-γ-Tubulin (IF Wholemount 1:500; Sigma T5192). ..

    other:

    Article Title: Developmental regulation of kinetochore phosphorylation determines mitotic fidelity
    Article Snippet: The following antibodies were used for IF: rabbit anti-OCT4 (Abcam #ab19857; 5 μg/mL), mouse anti-NANOG (Abcam #ab173368; 1:200), rabbit anti-MYC (Cell Signaling #13987; 1:1600), mouse anti-SOX2 (R&D Systems #MAB2018; 1:50), mouse anti-CENP-A (Thermo Scientific #MA1-20832; 1:400), guinea pig anti-CENP-C (MBL #PD030; 1:100), chicken anti-GFP (Abcam #ab13970; 1:1000), rabbit anti-Aurora B (Novus #NB100-294, 1:1000), mouse anti-Cyclin B1 (Santa Cruz #sc-245; 1:200), rabbit anti-Cyclin B2 (Abcam #ab185622; 1:500), rat anti-tyrosinated tubulin (Santa Cruz #sc-53029; 1:1000 or Novus #NB600-506; 1:2500), mouse anti-HEC1 (Santa Cruz #sc-515550; 1:500), rabbit anti-HEC1 S44 (gift of Jennifer DeLuca; 1:500), and rabbit anti-HEC1 pT31 (Duane Compton; 1:100,000).

    Article Title: Generation of an Alagille Syndrome (ALGS) patient-derived induced pluripotent stem cell line (TRNDi036-A) carrying a heterozygous mutation (p.Cys693*) in the JAG1 gene
    Article Snippet: Pluripotency Markers , Mouse anti-SOX2 , 1:200 , R & D systems, Cat# MAB2018 , RRID: AB_358009.



    Similar Products

    93
    Miltenyi Biotec sox2
    Reprogramming of adult human dermal fibroblasts (HDFa) into induced pluripotent stem cell (iPSC) line BO-VC1. Reprogramming was performed using the Epi5 ™ Episomal iPSC Reprogramming Kit, enabling the generation of ( A ) transgene- and virus-free iPSC line BO-VC1. Successful generation of fibroblast-derived iPSCs was validated by immunocytochemical staining for the pluripotency markers ( B ) <t>SOX2,</t> C TRA 1–60, D OCT4, SSEA4 and E NANOG. Quantification of the generated iPSCs via flow cytometry revealed F 99.31% SSEA4/TRA1-60, G 97.43% SOX2/TRA1-60 and H 98.60% OCT3/4/TRA1-60 positive cells. I Quantification of the transcript levels of the stem cell markers NANOG , OCT4 , REX1 and SOX2 revealed significantly higher mRNA levels in iPSC line BO-VC1 compared to the HDFa control ( n = 3 different passages) Moreover, generated iPSCs were functionally validated by directed differentiation into all three germ layers. Subsequent immunocytochemical staining of the iPSCs before and after differentiation confirmed the expression of ( J–M ) meso-, N–Q endo- and R–U ectodermal lineage markers only in the respective differentiations. Scale bars: 50 μm. Data were tested for normal distribution using Shapiro-Wilk test. Means ± SEM (standard error of the mean) were statistically analyzed by a Kruskal-Wallis test with Dunn’s multiple comparisons test. n = 3 (* p ≤ 0.05, ** p ≤ 0.01, *** p ≤ 0.001)
    Sox2, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mouse+anti+sox2/Sox2+Antibody%2C+anti-human%2Fmouse%2C+REAfinity/pmc13352860-131-60-63
    Average 93 stars, based on 1 article reviews
    sox2 - by Bioz Stars, 2026-09
    93/100 stars
      Buy from Supplier

    97
    R&D Systems anti sox2
    Reprogramming of adult human dermal fibroblasts (HDFa) into induced pluripotent stem cell (iPSC) line BO-VC1. Reprogramming was performed using the Epi5 ™ Episomal iPSC Reprogramming Kit, enabling the generation of ( A ) transgene- and virus-free iPSC line BO-VC1. Successful generation of fibroblast-derived iPSCs was validated by immunocytochemical staining for the pluripotency markers ( B ) <t>SOX2,</t> C TRA 1–60, D OCT4, SSEA4 and E NANOG. Quantification of the generated iPSCs via flow cytometry revealed F 99.31% SSEA4/TRA1-60, G 97.43% SOX2/TRA1-60 and H 98.60% OCT3/4/TRA1-60 positive cells. I Quantification of the transcript levels of the stem cell markers NANOG , OCT4 , REX1 and SOX2 revealed significantly higher mRNA levels in iPSC line BO-VC1 compared to the HDFa control ( n = 3 different passages) Moreover, generated iPSCs were functionally validated by directed differentiation into all three germ layers. Subsequent immunocytochemical staining of the iPSCs before and after differentiation confirmed the expression of ( J–M ) meso-, N–Q endo- and R–U ectodermal lineage markers only in the respective differentiations. Scale bars: 50 μm. Data were tested for normal distribution using Shapiro-Wilk test. Means ± SEM (standard error of the mean) were statistically analyzed by a Kruskal-Wallis test with Dunn’s multiple comparisons test. n = 3 (* p ≤ 0.05, ** p ≤ 0.01, *** p ≤ 0.001)
    Anti Sox2, supplied by R&D Systems, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mouse+anti+sox2/Human%2FMouse%2FRat+SOX2+Antibody/pm42032298-92-12-15
    Average 97 stars, based on 1 article reviews
    anti sox2 - by Bioz Stars, 2026-09
    97/100 stars
      Buy from Supplier

    97
    R&D Systems af2018 sp
    Reprogramming of adult human dermal fibroblasts (HDFa) into induced pluripotent stem cell (iPSC) line BO-VC1. Reprogramming was performed using the Epi5 ™ Episomal iPSC Reprogramming Kit, enabling the generation of ( A ) transgene- and virus-free iPSC line BO-VC1. Successful generation of fibroblast-derived iPSCs was validated by immunocytochemical staining for the pluripotency markers ( B ) <t>SOX2,</t> C TRA 1–60, D OCT4, SSEA4 and E NANOG. Quantification of the generated iPSCs via flow cytometry revealed F 99.31% SSEA4/TRA1-60, G 97.43% SOX2/TRA1-60 and H 98.60% OCT3/4/TRA1-60 positive cells. I Quantification of the transcript levels of the stem cell markers NANOG , OCT4 , REX1 and SOX2 revealed significantly higher mRNA levels in iPSC line BO-VC1 compared to the HDFa control ( n = 3 different passages) Moreover, generated iPSCs were functionally validated by directed differentiation into all three germ layers. Subsequent immunocytochemical staining of the iPSCs before and after differentiation confirmed the expression of ( J–M ) meso-, N–Q endo- and R–U ectodermal lineage markers only in the respective differentiations. Scale bars: 50 μm. Data were tested for normal distribution using Shapiro-Wilk test. Means ± SEM (standard error of the mean) were statistically analyzed by a Kruskal-Wallis test with Dunn’s multiple comparisons test. n = 3 (* p ≤ 0.05, ** p ≤ 0.01, *** p ≤ 0.001)
    Af2018 Sp, supplied by R&D Systems, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mouse+anti+sox2/Human%2FMouse%2FRat+SOX2+Antibody/pmc13101848-100-48-46
    Average 97 stars, based on 1 article reviews
    af2018 sp - by Bioz Stars, 2026-09
    97/100 stars
      Buy from Supplier

    96
    R&D Systems sox2
    Induction of Hb-LiNSCs (A) Schematic of the method used to induce human induced pluripotent stem cells (iPSCs) into Hb-LiNSCs. (B) Phase contrast images of iPSC and Hb-LiNSCs colonies, and differentiated neurons from left to right. Scale bars, 100 μm. Representative images ( n = 3, n represents the number of independent induction experiments). (C) E-cadherin ( CDH1 ), N-cadherin ( CDH2 ), SOX1 , <t>SOX2</t> , PAX6 , and POU5F1 gene expression in iNSCs during the induction phase relative to that on day 0 (iPS cells). Bars indicate means; error bars as SD ( n = 3, n represents the number of independent induction experiments). (D) Immunocytochemical staining for SOX1, SOX2, NESTIN, PAX6, NANOG, POU5F1, and that of nuclei with DAPI in Hb-LiNSCs at day 7 after induction of iPSCs. Scale bars, 50 μm. Representative images ( n = 3, n represents the number of independent induction experiments). (E) Heatmap of selected genes representing pluripotency, NSCs, differentiated neurons, and canonical markers for the hindbrain region, with hierarchical clustering of genes and samples. Three samples of 1231A3 iPS (as control) and three samples of 1231A3 Hb-LiNSCs at PN0 day 7 were used. Normalized gene expression data are represented by the color intensity of the row Z scores. (F) Log fold change values ( x axis) are plotted against significance (negative log 10 of p -adjusted value, y axis) for PN0 day 7 Hb-LiNSC samples (three samples) vs. 1231A3 iPS control (three samples). Red color dots indicate significantly differentially expressed genes. Vertical dashed lines indicate the threshold of 1.5 log fold change, and the horizontal dashed lines indicates the significance threshold ( p = 0.05). (G) Gene enrichment analysis of the significantly ( p < 0.05) upregulated (log 2 fold change ≥1.5) genes in the PN0 Day 7 Hb-LiNSCs vs. iPSC control comparison for selected datasets. Dot size indicates the number of genes overlapping with the dataset, color intensity indicates the significance (top 10 terms ordered by p values), and the x axis indicates the combined score calculated using Enrichr. Relevant terms are highlighted in red.
    Sox2, supplied by R&D Systems, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mouse+anti+sox2/Human%2FMouse%2FRat+SOX2+Antibody/pmc13107045-308-19-20
    Average 96 stars, based on 1 article reviews
    sox2 - by Bioz Stars, 2026-09
    96/100 stars
      Buy from Supplier

    96
    R&D Systems nestin
    Induction of Hb-LiNSCs (A) Schematic of the method used to induce human induced pluripotent stem cells (iPSCs) into Hb-LiNSCs. (B) Phase contrast images of iPSC and Hb-LiNSCs colonies, and differentiated neurons from left to right. Scale bars, 100 μm. Representative images ( n = 3, n represents the number of independent induction experiments). (C) E-cadherin ( CDH1 ), N-cadherin ( CDH2 <t>),</t> <t>SOX1</t> , SOX2 , PAX6 , and POU5F1 gene expression in iNSCs during the induction phase relative to that on day 0 (iPS cells). Bars indicate means; error bars as SD ( n = 3, n represents the number of independent induction experiments). (D) Immunocytochemical staining for SOX1, SOX2, <t>NESTIN,</t> PAX6, NANOG, POU5F1, and that of nuclei with DAPI in Hb-LiNSCs at day 7 after induction of iPSCs. Scale bars, 50 μm. Representative images ( n = 3, n represents the number of independent induction experiments). (E) Heatmap of selected genes representing pluripotency, NSCs, differentiated neurons, and canonical markers for the hindbrain region, with hierarchical clustering of genes and samples. Three samples of 1231A3 iPS (as control) and three samples of 1231A3 Hb-LiNSCs at PN0 day 7 were used. Normalized gene expression data are represented by the color intensity of the row Z scores. (F) Log fold change values ( x axis) are plotted against significance (negative log 10 of p -adjusted value, y axis) for PN0 day 7 Hb-LiNSC samples (three samples) vs. 1231A3 iPS control (three samples). Red color dots indicate significantly differentially expressed genes. Vertical dashed lines indicate the threshold of 1.5 log fold change, and the horizontal dashed lines indicates the significance threshold ( p = 0.05). (G) Gene enrichment analysis of the significantly ( p < 0.05) upregulated (log 2 fold change ≥1.5) genes in the PN0 Day 7 Hb-LiNSCs vs. iPSC control comparison for selected datasets. Dot size indicates the number of genes overlapping with the dataset, color intensity indicates the significance (top 10 terms ordered by p values), and the x axis indicates the combined score calculated using Enrichr. Relevant terms are highlighted in red.
    Nestin, supplied by R&D Systems, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mouse+anti+sox2/Human%2FMouse%2FRat+SOX2+Antibody/pmc13107045-308-23-24
    Average 96 stars, based on 1 article reviews
    nestin - by Bioz Stars, 2026-09
    96/100 stars
      Buy from Supplier

    97
    R&D Systems goat anti sox10
    Induction of Hb-LiNSCs (A) Schematic of the method used to induce human induced pluripotent stem cells (iPSCs) into Hb-LiNSCs. (B) Phase contrast images of iPSC and Hb-LiNSCs colonies, and differentiated neurons from left to right. Scale bars, 100 μm. Representative images ( n = 3, n represents the number of independent induction experiments). (C) E-cadherin ( CDH1 ), N-cadherin ( CDH2 <t>),</t> <t>SOX1</t> , SOX2 , PAX6 , and POU5F1 gene expression in iNSCs during the induction phase relative to that on day 0 (iPS cells). Bars indicate means; error bars as SD ( n = 3, n represents the number of independent induction experiments). (D) Immunocytochemical staining for SOX1, SOX2, <t>NESTIN,</t> PAX6, NANOG, POU5F1, and that of nuclei with DAPI in Hb-LiNSCs at day 7 after induction of iPSCs. Scale bars, 50 μm. Representative images ( n = 3, n represents the number of independent induction experiments). (E) Heatmap of selected genes representing pluripotency, NSCs, differentiated neurons, and canonical markers for the hindbrain region, with hierarchical clustering of genes and samples. Three samples of 1231A3 iPS (as control) and three samples of 1231A3 Hb-LiNSCs at PN0 day 7 were used. Normalized gene expression data are represented by the color intensity of the row Z scores. (F) Log fold change values ( x axis) are plotted against significance (negative log 10 of p -adjusted value, y axis) for PN0 day 7 Hb-LiNSC samples (three samples) vs. 1231A3 iPS control (three samples). Red color dots indicate significantly differentially expressed genes. Vertical dashed lines indicate the threshold of 1.5 log fold change, and the horizontal dashed lines indicates the significance threshold ( p = 0.05). (G) Gene enrichment analysis of the significantly ( p < 0.05) upregulated (log 2 fold change ≥1.5) genes in the PN0 Day 7 Hb-LiNSCs vs. iPSC control comparison for selected datasets. Dot size indicates the number of genes overlapping with the dataset, color intensity indicates the significance (top 10 terms ordered by p values), and the x axis indicates the combined score calculated using Enrichr. Relevant terms are highlighted in red.
    Goat Anti Sox10, supplied by R&D Systems, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mouse+anti+sox2/Human%2FMouse%2FRat+SOX2+Antibody/bio_rxiv__64898__2026__04__15__718827-238-38-42
    Average 97 stars, based on 1 article reviews
    goat anti sox10 - by Bioz Stars, 2026-09
    97/100 stars
      Buy from Supplier

    96
    R&D Systems mouse anti sox2
    Induction of Hb-LiNSCs (A) Schematic of the method used to induce human induced pluripotent stem cells (iPSCs) into Hb-LiNSCs. (B) Phase contrast images of iPSC and Hb-LiNSCs colonies, and differentiated neurons from left to right. Scale bars, 100 μm. Representative images ( n = 3, n represents the number of independent induction experiments). (C) E-cadherin ( CDH1 ), N-cadherin ( CDH2 <t>),</t> <t>SOX1</t> , SOX2 , PAX6 , and POU5F1 gene expression in iNSCs during the induction phase relative to that on day 0 (iPS cells). Bars indicate means; error bars as SD ( n = 3, n represents the number of independent induction experiments). (D) Immunocytochemical staining for SOX1, SOX2, <t>NESTIN,</t> PAX6, NANOG, POU5F1, and that of nuclei with DAPI in Hb-LiNSCs at day 7 after induction of iPSCs. Scale bars, 50 μm. Representative images ( n = 3, n represents the number of independent induction experiments). (E) Heatmap of selected genes representing pluripotency, NSCs, differentiated neurons, and canonical markers for the hindbrain region, with hierarchical clustering of genes and samples. Three samples of 1231A3 iPS (as control) and three samples of 1231A3 Hb-LiNSCs at PN0 day 7 were used. Normalized gene expression data are represented by the color intensity of the row Z scores. (F) Log fold change values ( x axis) are plotted against significance (negative log 10 of p -adjusted value, y axis) for PN0 day 7 Hb-LiNSC samples (three samples) vs. 1231A3 iPS control (three samples). Red color dots indicate significantly differentially expressed genes. Vertical dashed lines indicate the threshold of 1.5 log fold change, and the horizontal dashed lines indicates the significance threshold ( p = 0.05). (G) Gene enrichment analysis of the significantly ( p < 0.05) upregulated (log 2 fold change ≥1.5) genes in the PN0 Day 7 Hb-LiNSCs vs. iPSC control comparison for selected datasets. Dot size indicates the number of genes overlapping with the dataset, color intensity indicates the significance (top 10 terms ordered by p values), and the x axis indicates the combined score calculated using Enrichr. Relevant terms are highlighted in red.
    Mouse Anti Sox2, supplied by R&D Systems, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mouse+anti+sox2/Human%2FMouse%2FRat+SOX2+Antibody/bio_rxiv__64898__2026__04__15__718713-205-24-26
    Average 96 stars, based on 1 article reviews
    mouse anti sox2 - by Bioz Stars, 2026-09
    96/100 stars
      Buy from Supplier

    Image Search Results


    Reprogramming of adult human dermal fibroblasts (HDFa) into induced pluripotent stem cell (iPSC) line BO-VC1. Reprogramming was performed using the Epi5 ™ Episomal iPSC Reprogramming Kit, enabling the generation of ( A ) transgene- and virus-free iPSC line BO-VC1. Successful generation of fibroblast-derived iPSCs was validated by immunocytochemical staining for the pluripotency markers ( B ) SOX2, C TRA 1–60, D OCT4, SSEA4 and E NANOG. Quantification of the generated iPSCs via flow cytometry revealed F 99.31% SSEA4/TRA1-60, G 97.43% SOX2/TRA1-60 and H 98.60% OCT3/4/TRA1-60 positive cells. I Quantification of the transcript levels of the stem cell markers NANOG , OCT4 , REX1 and SOX2 revealed significantly higher mRNA levels in iPSC line BO-VC1 compared to the HDFa control ( n = 3 different passages) Moreover, generated iPSCs were functionally validated by directed differentiation into all three germ layers. Subsequent immunocytochemical staining of the iPSCs before and after differentiation confirmed the expression of ( J–M ) meso-, N–Q endo- and R–U ectodermal lineage markers only in the respective differentiations. Scale bars: 50 μm. Data were tested for normal distribution using Shapiro-Wilk test. Means ± SEM (standard error of the mean) were statistically analyzed by a Kruskal-Wallis test with Dunn’s multiple comparisons test. n = 3 (* p ≤ 0.05, ** p ≤ 0.01, *** p ≤ 0.001)

    Journal: Stem Cell Research & Therapy

    Article Title: Activation of the G-protein coupled estrogen receptor 1 (GPER1) reduces transient receptor potential vanilloid 1 (TRPV1) activity and human iPSC-derived nociceptive neuron firing

    doi: 10.1186/s13287-026-05174-3

    Figure Lengend Snippet: Reprogramming of adult human dermal fibroblasts (HDFa) into induced pluripotent stem cell (iPSC) line BO-VC1. Reprogramming was performed using the Epi5 ™ Episomal iPSC Reprogramming Kit, enabling the generation of ( A ) transgene- and virus-free iPSC line BO-VC1. Successful generation of fibroblast-derived iPSCs was validated by immunocytochemical staining for the pluripotency markers ( B ) SOX2, C TRA 1–60, D OCT4, SSEA4 and E NANOG. Quantification of the generated iPSCs via flow cytometry revealed F 99.31% SSEA4/TRA1-60, G 97.43% SOX2/TRA1-60 and H 98.60% OCT3/4/TRA1-60 positive cells. I Quantification of the transcript levels of the stem cell markers NANOG , OCT4 , REX1 and SOX2 revealed significantly higher mRNA levels in iPSC line BO-VC1 compared to the HDFa control ( n = 3 different passages) Moreover, generated iPSCs were functionally validated by directed differentiation into all three germ layers. Subsequent immunocytochemical staining of the iPSCs before and after differentiation confirmed the expression of ( J–M ) meso-, N–Q endo- and R–U ectodermal lineage markers only in the respective differentiations. Scale bars: 50 μm. Data were tested for normal distribution using Shapiro-Wilk test. Means ± SEM (standard error of the mean) were statistically analyzed by a Kruskal-Wallis test with Dunn’s multiple comparisons test. n = 3 (* p ≤ 0.05, ** p ≤ 0.01, *** p ≤ 0.001)

    Article Snippet: Subsequently, cells were incubated in inside fix solution of the Inside Stain Kit (#130-090-477, Miltenyi Biotec, Bergisch Gladbach, Germany) for 20 min at RT and centrifuged at 200xg for 5 min. After washing in 500 μl PEB buffer and centrifugation at 200xg cells were stained with the nuclear stem cell markers OCT3/4 (1:50, #130-117-821, Miltenyi Biotec, Bergisch Gladbach, Germany) and SOX2 (1:50, #130-120-790, Miltenyi Biotec, Bergisch Gladbach, Germany) in inside perm solution for 10 min at RT.

    Techniques: Virus, Derivative Assay, Staining, Generated, Flow Cytometry, Control, Expressing

    Induction of Hb-LiNSCs (A) Schematic of the method used to induce human induced pluripotent stem cells (iPSCs) into Hb-LiNSCs. (B) Phase contrast images of iPSC and Hb-LiNSCs colonies, and differentiated neurons from left to right. Scale bars, 100 μm. Representative images ( n = 3, n represents the number of independent induction experiments). (C) E-cadherin ( CDH1 ), N-cadherin ( CDH2 ), SOX1 , SOX2 , PAX6 , and POU5F1 gene expression in iNSCs during the induction phase relative to that on day 0 (iPS cells). Bars indicate means; error bars as SD ( n = 3, n represents the number of independent induction experiments). (D) Immunocytochemical staining for SOX1, SOX2, NESTIN, PAX6, NANOG, POU5F1, and that of nuclei with DAPI in Hb-LiNSCs at day 7 after induction of iPSCs. Scale bars, 50 μm. Representative images ( n = 3, n represents the number of independent induction experiments). (E) Heatmap of selected genes representing pluripotency, NSCs, differentiated neurons, and canonical markers for the hindbrain region, with hierarchical clustering of genes and samples. Three samples of 1231A3 iPS (as control) and three samples of 1231A3 Hb-LiNSCs at PN0 day 7 were used. Normalized gene expression data are represented by the color intensity of the row Z scores. (F) Log fold change values ( x axis) are plotted against significance (negative log 10 of p -adjusted value, y axis) for PN0 day 7 Hb-LiNSC samples (three samples) vs. 1231A3 iPS control (three samples). Red color dots indicate significantly differentially expressed genes. Vertical dashed lines indicate the threshold of 1.5 log fold change, and the horizontal dashed lines indicates the significance threshold ( p = 0.05). (G) Gene enrichment analysis of the significantly ( p < 0.05) upregulated (log 2 fold change ≥1.5) genes in the PN0 Day 7 Hb-LiNSCs vs. iPSC control comparison for selected datasets. Dot size indicates the number of genes overlapping with the dataset, color intensity indicates the significance (top 10 terms ordered by p values), and the x axis indicates the combined score calculated using Enrichr. Relevant terms are highlighted in red.

    Journal: Cell Reports Methods

    Article Title: Wnt activation and dual SMAD inhibition for induction and maintenance of hindbrain-like neural stem cell from hiPSCs

    doi: 10.1016/j.crmeth.2026.101372

    Figure Lengend Snippet: Induction of Hb-LiNSCs (A) Schematic of the method used to induce human induced pluripotent stem cells (iPSCs) into Hb-LiNSCs. (B) Phase contrast images of iPSC and Hb-LiNSCs colonies, and differentiated neurons from left to right. Scale bars, 100 μm. Representative images ( n = 3, n represents the number of independent induction experiments). (C) E-cadherin ( CDH1 ), N-cadherin ( CDH2 ), SOX1 , SOX2 , PAX6 , and POU5F1 gene expression in iNSCs during the induction phase relative to that on day 0 (iPS cells). Bars indicate means; error bars as SD ( n = 3, n represents the number of independent induction experiments). (D) Immunocytochemical staining for SOX1, SOX2, NESTIN, PAX6, NANOG, POU5F1, and that of nuclei with DAPI in Hb-LiNSCs at day 7 after induction of iPSCs. Scale bars, 50 μm. Representative images ( n = 3, n represents the number of independent induction experiments). (E) Heatmap of selected genes representing pluripotency, NSCs, differentiated neurons, and canonical markers for the hindbrain region, with hierarchical clustering of genes and samples. Three samples of 1231A3 iPS (as control) and three samples of 1231A3 Hb-LiNSCs at PN0 day 7 were used. Normalized gene expression data are represented by the color intensity of the row Z scores. (F) Log fold change values ( x axis) are plotted against significance (negative log 10 of p -adjusted value, y axis) for PN0 day 7 Hb-LiNSC samples (three samples) vs. 1231A3 iPS control (three samples). Red color dots indicate significantly differentially expressed genes. Vertical dashed lines indicate the threshold of 1.5 log fold change, and the horizontal dashed lines indicates the significance threshold ( p = 0.05). (G) Gene enrichment analysis of the significantly ( p < 0.05) upregulated (log 2 fold change ≥1.5) genes in the PN0 Day 7 Hb-LiNSCs vs. iPSC control comparison for selected datasets. Dot size indicates the number of genes overlapping with the dataset, color intensity indicates the significance (top 10 terms ordered by p values), and the x axis indicates the combined score calculated using Enrichr. Relevant terms are highlighted in red.

    Article Snippet: Hb-LiNSCs and/or attached neurospheres were fixed with 4% paraformaldehyde and then stained with antibodies against SOX1 (Cell Signaling, 4194S), SOX2 (R&D systems, MAB2018), NESTIN (R&D systems, MAB1259), NANOG (R&D systems, AF1997), POU5F1 (Santa Cruz Biotechnology, sc-5279), PAX6 (Abcam, EPR15858 ), TUBB3 (GeneTex, GTX85469), OLIG2 (GeneTex, GTX132732), or GFAP (Santa Cruz Biotechnology, sc-33673), and with DAPI for the nuclei.

    Techniques: Gene Expression, Staining, Control, Comparison

    Long-term maintenance of Hb-LiNSCs (A) Schematic of the maintenance plan (on the left). Hb-LiNSCs were passaged every week, and thereafter, at every fifth passage, one clone of cells was cryopreserved, one was used to extract bulk RNA, and one was used for maintaining the culture. The grouping into early, mid, and late samples according to the passage number is shown on the right. (B) Karyotyping of Hb-LiNSCs at PN53 derived from the 1231A3 human iPSC line. (C) Immunocytochemical staining of Hb-LiNSCs for TUBB3, SOX1, NESTIN, PAX6, NANOG, and SOX2, and that of nuclei with DAPI at PN60 (60 weeks) after induction of iPSCs. Scale bars, 50 μm. Representative images ( n = 3, n represents the number of independent induction experiments). (D) Heatmap of selected genes representing pluripotency, NSC, neural differentiation, and canonical markers for different brain regions, with hierarchical clustering of genes. The colored bar on the top indicates the samples. Samples PN5_1 to PN5_3 and PN60_1 to PN60_3 were derived from the 1231A3 iPSC line. Samples PN5_4 and PN5_5 were derived from HLAKO and SgT5 iPSC lines, respectively. “_diff” stands for differentiated neurons. Normalized gene expression data are represented by the color intensity of the row Z scores. (E) PCA plots of the first and second (PC1 and PC2) components for the iPSC control are indicated in red, and Hb-LiNSCs and their differentiated cells at early-, mid-, and late-passage numbers are indicated in green, purple, and blue, respectively. (F) Gene enrichment analysis of the significantly ( p < 0.05) upregulated (log 2 fold change ≥ 1.5) genes in the late PN group vs. iPSC control comparison for selected datasets. Dot size indicates the number of genes overlapping with the dataset, color intensity indicates the significance (top 10 terms ordered by p values), and the x axis indicates the combined score calculated using Enrichr. Relevant terms are highlighted in red. (G) Pairwise correlation heatmap showing the relationships among samples. The color intensity in the heatmap indicates the correlation, ranging from 1 (positive correlation) in red through 0 (no correlation) in white to −1 (negative correlation) in green.

    Journal: Cell Reports Methods

    Article Title: Wnt activation and dual SMAD inhibition for induction and maintenance of hindbrain-like neural stem cell from hiPSCs

    doi: 10.1016/j.crmeth.2026.101372

    Figure Lengend Snippet: Long-term maintenance of Hb-LiNSCs (A) Schematic of the maintenance plan (on the left). Hb-LiNSCs were passaged every week, and thereafter, at every fifth passage, one clone of cells was cryopreserved, one was used to extract bulk RNA, and one was used for maintaining the culture. The grouping into early, mid, and late samples according to the passage number is shown on the right. (B) Karyotyping of Hb-LiNSCs at PN53 derived from the 1231A3 human iPSC line. (C) Immunocytochemical staining of Hb-LiNSCs for TUBB3, SOX1, NESTIN, PAX6, NANOG, and SOX2, and that of nuclei with DAPI at PN60 (60 weeks) after induction of iPSCs. Scale bars, 50 μm. Representative images ( n = 3, n represents the number of independent induction experiments). (D) Heatmap of selected genes representing pluripotency, NSC, neural differentiation, and canonical markers for different brain regions, with hierarchical clustering of genes. The colored bar on the top indicates the samples. Samples PN5_1 to PN5_3 and PN60_1 to PN60_3 were derived from the 1231A3 iPSC line. Samples PN5_4 and PN5_5 were derived from HLAKO and SgT5 iPSC lines, respectively. “_diff” stands for differentiated neurons. Normalized gene expression data are represented by the color intensity of the row Z scores. (E) PCA plots of the first and second (PC1 and PC2) components for the iPSC control are indicated in red, and Hb-LiNSCs and their differentiated cells at early-, mid-, and late-passage numbers are indicated in green, purple, and blue, respectively. (F) Gene enrichment analysis of the significantly ( p < 0.05) upregulated (log 2 fold change ≥ 1.5) genes in the late PN group vs. iPSC control comparison for selected datasets. Dot size indicates the number of genes overlapping with the dataset, color intensity indicates the significance (top 10 terms ordered by p values), and the x axis indicates the combined score calculated using Enrichr. Relevant terms are highlighted in red. (G) Pairwise correlation heatmap showing the relationships among samples. The color intensity in the heatmap indicates the correlation, ranging from 1 (positive correlation) in red through 0 (no correlation) in white to −1 (negative correlation) in green.

    Article Snippet: Hb-LiNSCs and/or attached neurospheres were fixed with 4% paraformaldehyde and then stained with antibodies against SOX1 (Cell Signaling, 4194S), SOX2 (R&D systems, MAB2018), NESTIN (R&D systems, MAB1259), NANOG (R&D systems, AF1997), POU5F1 (Santa Cruz Biotechnology, sc-5279), PAX6 (Abcam, EPR15858 ), TUBB3 (GeneTex, GTX85469), OLIG2 (GeneTex, GTX132732), or GFAP (Santa Cruz Biotechnology, sc-33673), and with DAPI for the nuclei.

    Techniques: Derivative Assay, Staining, Gene Expression, Control, Comparison

    Induction of Hb-LiNSCs (A) Schematic of the method used to induce human induced pluripotent stem cells (iPSCs) into Hb-LiNSCs. (B) Phase contrast images of iPSC and Hb-LiNSCs colonies, and differentiated neurons from left to right. Scale bars, 100 μm. Representative images ( n = 3, n represents the number of independent induction experiments). (C) E-cadherin ( CDH1 ), N-cadherin ( CDH2 ), SOX1 , SOX2 , PAX6 , and POU5F1 gene expression in iNSCs during the induction phase relative to that on day 0 (iPS cells). Bars indicate means; error bars as SD ( n = 3, n represents the number of independent induction experiments). (D) Immunocytochemical staining for SOX1, SOX2, NESTIN, PAX6, NANOG, POU5F1, and that of nuclei with DAPI in Hb-LiNSCs at day 7 after induction of iPSCs. Scale bars, 50 μm. Representative images ( n = 3, n represents the number of independent induction experiments). (E) Heatmap of selected genes representing pluripotency, NSCs, differentiated neurons, and canonical markers for the hindbrain region, with hierarchical clustering of genes and samples. Three samples of 1231A3 iPS (as control) and three samples of 1231A3 Hb-LiNSCs at PN0 day 7 were used. Normalized gene expression data are represented by the color intensity of the row Z scores. (F) Log fold change values ( x axis) are plotted against significance (negative log 10 of p -adjusted value, y axis) for PN0 day 7 Hb-LiNSC samples (three samples) vs. 1231A3 iPS control (three samples). Red color dots indicate significantly differentially expressed genes. Vertical dashed lines indicate the threshold of 1.5 log fold change, and the horizontal dashed lines indicates the significance threshold ( p = 0.05). (G) Gene enrichment analysis of the significantly ( p < 0.05) upregulated (log 2 fold change ≥1.5) genes in the PN0 Day 7 Hb-LiNSCs vs. iPSC control comparison for selected datasets. Dot size indicates the number of genes overlapping with the dataset, color intensity indicates the significance (top 10 terms ordered by p values), and the x axis indicates the combined score calculated using Enrichr. Relevant terms are highlighted in red.

    Journal: Cell Reports Methods

    Article Title: Wnt activation and dual SMAD inhibition for induction and maintenance of hindbrain-like neural stem cell from hiPSCs

    doi: 10.1016/j.crmeth.2026.101372

    Figure Lengend Snippet: Induction of Hb-LiNSCs (A) Schematic of the method used to induce human induced pluripotent stem cells (iPSCs) into Hb-LiNSCs. (B) Phase contrast images of iPSC and Hb-LiNSCs colonies, and differentiated neurons from left to right. Scale bars, 100 μm. Representative images ( n = 3, n represents the number of independent induction experiments). (C) E-cadherin ( CDH1 ), N-cadherin ( CDH2 ), SOX1 , SOX2 , PAX6 , and POU5F1 gene expression in iNSCs during the induction phase relative to that on day 0 (iPS cells). Bars indicate means; error bars as SD ( n = 3, n represents the number of independent induction experiments). (D) Immunocytochemical staining for SOX1, SOX2, NESTIN, PAX6, NANOG, POU5F1, and that of nuclei with DAPI in Hb-LiNSCs at day 7 after induction of iPSCs. Scale bars, 50 μm. Representative images ( n = 3, n represents the number of independent induction experiments). (E) Heatmap of selected genes representing pluripotency, NSCs, differentiated neurons, and canonical markers for the hindbrain region, with hierarchical clustering of genes and samples. Three samples of 1231A3 iPS (as control) and three samples of 1231A3 Hb-LiNSCs at PN0 day 7 were used. Normalized gene expression data are represented by the color intensity of the row Z scores. (F) Log fold change values ( x axis) are plotted against significance (negative log 10 of p -adjusted value, y axis) for PN0 day 7 Hb-LiNSC samples (three samples) vs. 1231A3 iPS control (three samples). Red color dots indicate significantly differentially expressed genes. Vertical dashed lines indicate the threshold of 1.5 log fold change, and the horizontal dashed lines indicates the significance threshold ( p = 0.05). (G) Gene enrichment analysis of the significantly ( p < 0.05) upregulated (log 2 fold change ≥1.5) genes in the PN0 Day 7 Hb-LiNSCs vs. iPSC control comparison for selected datasets. Dot size indicates the number of genes overlapping with the dataset, color intensity indicates the significance (top 10 terms ordered by p values), and the x axis indicates the combined score calculated using Enrichr. Relevant terms are highlighted in red.

    Article Snippet: Hb-LiNSCs and/or attached neurospheres were fixed with 4% paraformaldehyde and then stained with antibodies against SOX1 (Cell Signaling, 4194S), SOX2 (R&D systems, MAB2018), NESTIN (R&D systems, MAB1259), NANOG (R&D systems, AF1997), POU5F1 (Santa Cruz Biotechnology, sc-5279), PAX6 (Abcam, EPR15858 ), TUBB3 (GeneTex, GTX85469), OLIG2 (GeneTex, GTX132732), or GFAP (Santa Cruz Biotechnology, sc-33673), and with DAPI for the nuclei.

    Techniques: Gene Expression, Staining, Control, Comparison

    Long-term maintenance of Hb-LiNSCs (A) Schematic of the maintenance plan (on the left). Hb-LiNSCs were passaged every week, and thereafter, at every fifth passage, one clone of cells was cryopreserved, one was used to extract bulk RNA, and one was used for maintaining the culture. The grouping into early, mid, and late samples according to the passage number is shown on the right. (B) Karyotyping of Hb-LiNSCs at PN53 derived from the 1231A3 human iPSC line. (C) Immunocytochemical staining of Hb-LiNSCs for TUBB3, SOX1, NESTIN, PAX6, NANOG, and SOX2, and that of nuclei with DAPI at PN60 (60 weeks) after induction of iPSCs. Scale bars, 50 μm. Representative images ( n = 3, n represents the number of independent induction experiments). (D) Heatmap of selected genes representing pluripotency, NSC, neural differentiation, and canonical markers for different brain regions, with hierarchical clustering of genes. The colored bar on the top indicates the samples. Samples PN5_1 to PN5_3 and PN60_1 to PN60_3 were derived from the 1231A3 iPSC line. Samples PN5_4 and PN5_5 were derived from HLAKO and SgT5 iPSC lines, respectively. “_diff” stands for differentiated neurons. Normalized gene expression data are represented by the color intensity of the row Z scores. (E) PCA plots of the first and second (PC1 and PC2) components for the iPSC control are indicated in red, and Hb-LiNSCs and their differentiated cells at early-, mid-, and late-passage numbers are indicated in green, purple, and blue, respectively. (F) Gene enrichment analysis of the significantly ( p < 0.05) upregulated (log 2 fold change ≥ 1.5) genes in the late PN group vs. iPSC control comparison for selected datasets. Dot size indicates the number of genes overlapping with the dataset, color intensity indicates the significance (top 10 terms ordered by p values), and the x axis indicates the combined score calculated using Enrichr. Relevant terms are highlighted in red. (G) Pairwise correlation heatmap showing the relationships among samples. The color intensity in the heatmap indicates the correlation, ranging from 1 (positive correlation) in red through 0 (no correlation) in white to −1 (negative correlation) in green.

    Journal: Cell Reports Methods

    Article Title: Wnt activation and dual SMAD inhibition for induction and maintenance of hindbrain-like neural stem cell from hiPSCs

    doi: 10.1016/j.crmeth.2026.101372

    Figure Lengend Snippet: Long-term maintenance of Hb-LiNSCs (A) Schematic of the maintenance plan (on the left). Hb-LiNSCs were passaged every week, and thereafter, at every fifth passage, one clone of cells was cryopreserved, one was used to extract bulk RNA, and one was used for maintaining the culture. The grouping into early, mid, and late samples according to the passage number is shown on the right. (B) Karyotyping of Hb-LiNSCs at PN53 derived from the 1231A3 human iPSC line. (C) Immunocytochemical staining of Hb-LiNSCs for TUBB3, SOX1, NESTIN, PAX6, NANOG, and SOX2, and that of nuclei with DAPI at PN60 (60 weeks) after induction of iPSCs. Scale bars, 50 μm. Representative images ( n = 3, n represents the number of independent induction experiments). (D) Heatmap of selected genes representing pluripotency, NSC, neural differentiation, and canonical markers for different brain regions, with hierarchical clustering of genes. The colored bar on the top indicates the samples. Samples PN5_1 to PN5_3 and PN60_1 to PN60_3 were derived from the 1231A3 iPSC line. Samples PN5_4 and PN5_5 were derived from HLAKO and SgT5 iPSC lines, respectively. “_diff” stands for differentiated neurons. Normalized gene expression data are represented by the color intensity of the row Z scores. (E) PCA plots of the first and second (PC1 and PC2) components for the iPSC control are indicated in red, and Hb-LiNSCs and their differentiated cells at early-, mid-, and late-passage numbers are indicated in green, purple, and blue, respectively. (F) Gene enrichment analysis of the significantly ( p < 0.05) upregulated (log 2 fold change ≥ 1.5) genes in the late PN group vs. iPSC control comparison for selected datasets. Dot size indicates the number of genes overlapping with the dataset, color intensity indicates the significance (top 10 terms ordered by p values), and the x axis indicates the combined score calculated using Enrichr. Relevant terms are highlighted in red. (G) Pairwise correlation heatmap showing the relationships among samples. The color intensity in the heatmap indicates the correlation, ranging from 1 (positive correlation) in red through 0 (no correlation) in white to −1 (negative correlation) in green.

    Article Snippet: Hb-LiNSCs and/or attached neurospheres were fixed with 4% paraformaldehyde and then stained with antibodies against SOX1 (Cell Signaling, 4194S), SOX2 (R&D systems, MAB2018), NESTIN (R&D systems, MAB1259), NANOG (R&D systems, AF1997), POU5F1 (Santa Cruz Biotechnology, sc-5279), PAX6 (Abcam, EPR15858 ), TUBB3 (GeneTex, GTX85469), OLIG2 (GeneTex, GTX132732), or GFAP (Santa Cruz Biotechnology, sc-33673), and with DAPI for the nuclei.

    Techniques: Derivative Assay, Staining, Gene Expression, Control, Comparison